ISRG
Earnings season, but make it robotic
Intuitive Surgical is heading into its Thursday, July 16 Q2 earnings report with analysts already sharpening their pencils. The Street is expecting $2.50 a share in profit on $2.82 billion in revenue, which would be a nice step up from the same quarter last year.
The analyst chorus keeps changing the tune
This piece also reads like a mini Wall Street group chat. BMO Capital’s Vik Chopra kicked things off with a fresh Outperform call and a $518 target, while Evercore ISI’s Vijay Kumar trimmed his target to $430. B of A, Barclays, and Leerink all stayed bullish-ish too, just with slightly less enthusiasm than before.
That matters because ISRG isn’t your average ticker with a single gimmick. When a company sells robotic surgery systems, investors want to know two things: are hospitals still buying the machines, and are procedures still humming along? If either answer gets fuzzy, the stock can start acting like it drank three espressos.
What you should watch
The real question is whether the earnings call confirms that the surgical-robot gravy train is still rolling. If results come in hot, the recent analyst optimism has room to breathe. If not, those price-target cuts may look less like caution and more like foreshadowing.
Big picture: this is less about one quarter and more about whether ISRG can keep proving its moat is still as wide as ever.